Funder · Federal agency

National Center for Advancing Translational Sciences

Connects National Center for Advancing Translational Sciences to support practical collaboration across research and industry.

United States

Key stats

Annual funding-

Programs11

Active grants8

Total grants11

About

The National Center for Advancing Translational Sciences, or NCATS, is an NIH center built to improve how discoveries move into patient care. It funds translational science methods, tools, and workforce rather than disease-specific research, and it sits inside the National Institutes of Health under the Department of Health and Human Services. Its role is to strengthen the machinery of translation…

Programs & grants under this funder

NCATS Translational Science Education and Training Challenge

Awards five $10,000 prizes for standout translational-science education and training programs.

1 grant

NCATS Translational Science Education and Training Challenge

Closed

$50K pool

NIH Quantum Computing Challenge

Awards up to $1.3 million across stages for new quantum algorithms solving biomedical problems.

1 grant

NIH Quantum Computing Challenge

Closed

$1.3M pool

NIH Quantum Sensing Technology Challenge

Awards up to $1.6 million across stages for quantum-enabled biomedical sensing devices.

1 grant

NIH Quantum Sensing Technology Challenge

Closed

$1.6M pool

Oligonucleotide Toxicity (OligoTox) Open Data Challenge

Pays cash prizes for public datasets that help predict oligonucleotide drug toxicity in human cells.

1 grant

Oligonucleotide Toxicity (OligoTox) Open Data Challenge

Open

$500K pool

ASPIRE — Specialized Platform for Innovative Research Exploration

Funds advanced research platforms in automation, microfluidics, and machine learning for translational science.

1 grant

ASPIRE Reduction-to-Practice (Seed)

Open

- pool·Rolling submission

NCATS Clinical Trial Readiness for Rare Diseases

Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.

1 grant

NCATS Clinical Trial Readiness for Rare Diseases

Open

- pool

Clinical and Translational Science Awards (CTSA)

Supports academic medical centres through cooperative agreements to strengthen translational science infrastructure.

NCATS Preclinical Proof of Concept Studies for Rare Diseases

Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.

1 grant

NCATS Preclinical Proof of Concept Studies for Rare Diseases

Open

$1.2M pool

Rare Diseases Clinical Research Network (RDCRN)

Funds consortiums across multiple sites to study many rare diseases and improve trial coordination.

NCATS SBIR/STTR Small Business Programs

Funds small United States businesses building translational science tools and research platforms.

Funds U.S. small businesses and their nonprofit research partners to conduct feasibility studies on translational science innovations toward commercialization.

Parent entityNational Institutes of Health

Work at NCATS? Claim this page